%D8%B1%D9%8A%D8%AA%D9%88%D9%86%D8%A7%D9%81%D9%8A%D8%B1%D8%B1%DB%8C%D8%AA%D9%88%D9%86%D8%A7%D9%88%DB%8C%D8%B1Category:RitonavirRitonafirRitonavirRitonavirRitonavir%D8%B1%DB%8C%D8%AA%D9%88%D9%86%D8%A7%D9%88%DB%8C%D8%B1RitonaviiriRitonavirRitonavir%E3%83%AA%E3%83%88%E3%83%8A%E3%83%93%E3%83%AB%EB%A6%AC%ED%86%A0%EB%82%98%EB%B9%84%EB%A5%B4%E0%AC%B0%E0%AC%BF%E0%AC%9F%E0%AD%8B%E0%AC%A8%E0%AC%BE%E0%AC%AD%E0%AC%BF%E0%AC%B0Rytonawir%D8%B1%D9%8A%D9%BC%D9%88%D9%86%D8%A7%D9%88%D9%8A%D8%B1RitonavirRitonavir%D0%9A%D0%B0%D1%82%D0%B5%D0%B3%D0%BE%D1%80%D0%B8%D1%8F:%D0%A0%D0%B8%D1%82%D0%BE%D0%BD%D0%B0%D0%B2%D0%B8%D1%80%D0%A0%D0%B8%D1%82%D0%BE%D0%BD%D0%B0%D0%B2%D0%B8%D1%80RitonavirRitonavirRitonavir%E0%B0%B0%E0%B0%BF%E0%B0%9F%E0%B0%A8%E0%B1%8B%E0%B0%B5%E0%B0%BF%E0%B0%B0%E0%B1%8D%E0%B8%A3%E0%B8%B4%E0%B9%82%E0%B8%95%E0%B8%99%E0%B8%B2%E0%B9%80%E0%B8%A7%E0%B8%B5%E0%B8%A2%E0%B8%A3%E0%B9%8C%D0%A0%D0%B8%D1%82%D0%BE%D0%BD%D0%B0%D0%B2%D1%96%D1%80RitonavirQ422618%E5%88%A9%E6%89%98%E9%82%A3%E9%9F%8B
about
P3781
The Influence of Ritonavir, Alone and in Combination With Lopinavir, on Fenofibric Acid Pharmacokinetics in Healthy VolunteersSimplified Treatment of Anti-retrovirus in China (C-STAR)Evaluation of Third-line cART Regimen in Cambodia (3DICAM)Treatment of Chronic Delta Hepatitis With Lonafarnib, Ritonavir and Lambda InterferonPharmacokinetics of Rifabutin Combined With Antiretroviral Therapy in Patients With TB/HIV Co-infection in South AfricaComparison of Efficacy and Safety of Infant Peri-exposure Prophylaxis With Lopinavir/Ritonavir Versus Lamivudine to Prevent HIV-1 Transmission by BreastfeedingPreservation and Expansion of T-cell Subsets Following HAART De-intensification to Atazanavir/Ritonavir (ATV/r)Pharmacokinetic Interactions Between Buprenorphine and Tipranavir/RitonavirEfficacy and Tolerance of the Switch From Enfuvirtine to Raltegravir in Antiretroviral Therapy Regimen in HIV Patients With Undetectable Viral LoadHIV-1 Infection Study of Once a Day Versus Twice a Day Protease Inhibitor in Antiretroviral Treatment Naive AdultsOptimizing Pediatric HIV-1 Treatment in Infants With Prophylactic Exposure to Nevirapine, Nairobi, KenyaSHARE: Simple HAART With Abacavir, Reyataz, and EpivirPrevention of HIV1 Mother to Child Transmission Without Nucleoside Analogue Reverse Transcriptase Inhibitors in the Pre-partum Phase. ANRS 135 PrimevaStudy Comparing Efficacy and Safety of Darunavir Boosted With Ritonavir to HART With 2 NRTI and Darunavir Boosted With Ritonavir in HIV-1 Infected Patients ANRS136Pharmacokinetic Study of Two HIV Protease Inhibitors in PatientsSafety and Antiviral Activity of TPV in HCV and/or HBV HIV Coinfected Patients TDM Randomised Pilot EvaluationSafety of EVG+RTV Administered With Other Antiretroviral Agents for the Treatment of HIV-1 InfectionAnti-Retrovirals for Kaposi's SarcomaMK0518 in the Treatment of HIV-Infected Patients Switched From a Protease Inhibitor Regimen (0518-033)(TERMINATED)MK0518 in the Treatment of HIV-Infected Patients Switched From a Protease Inhibitor Regimen (0518-032)(TERMINATED)Drug Interaction Study With Famotidine, Atazanavir, and Atazanavir/Ritonavir/TenofovirA Study of an Investigational Regimen Combining FDA Approved HIV Drugs in HIV-Infected SubjectsDrug Interaction Study With Atazanavir Administered With and Without Ritonavir and a Cytochrome P450 Substrate RosiglitazonePRINCE: Study of Atazanavir (ATV)/Ritonavir (RTV)Ritonavir and Lopinavir in Treating Patients With Progressive or Recurrent High-Grade GliomaStudy in Healthy Adults to Evaluate the Bioavailability of Two Test Tablet Formulations of ABT-450Special Investigation of Kaletra in Pregnant WomenDrug Use Investigation of KaletraClinical, Virological and Safety Outcomes of a Lopinavir/Ritonavir-Based Regimen in HIV-1 Infected Patients in Routine Clinical Use in ChinaA Randomized Study to Evaluate the Safety, Tolerability and Antiviral Activity of ABT-450, ABT-333 and ABT-072Atazanavir/Ritonavir and Darunavir/Ritonavir PK Tail StudyDrug Interaction Study Between GSK1349572 and Tipranavir/Ritonavir in Healthy VolunteersKaletra and Maraviroc in Antiretroviral Therapy (ART)-Naive Patients (KALMAR Study)Study of Darunavir/r + Tenofovir/Emtricitabine vs. Darunavir/r + Raltegravir in HIV-infected Antiretroviral naïve SubjectsStudy to Evaluate the Activity and Tolerability of Lopinavir/Ritonavir and Lamivudine Bitherapy in HIV Patients With Viral SuppressionBone and Body Comp: A Sub Study of the SECOND-LINE StudyEfficacy of Atazanavir/Ritonavir Monotherapy as Maintenance in Patients With Viral SuppressionABT-450 With Ritonavir and ABT-267 and/or ABT-333 With and Without Ribavirin in Genotype 1 Hepatitis C Virus Infected PatientsTrial To Assess The Lipid-Lowering Effect Of Adding Tenofovir/Emtricitabine Co-Formulation Vs Placebo To Hiv-1-Infected Subjects With Dyslipidemia And Sustained Viral Load Suppression Under Monotherapy With Ritonavir-Boosted Protease InhibitorsA Study to Evaluate Paritaprevir With Ritonavir (ABT-450/r) When Given Together With Ombitasvir and With and Without Ribavirin (RBV) in Treatment-Naïve Participants With Genotype 1, 2 or 3 Chronic Hepatitis C Virus (HCV)
P4844
Elucidation of crystal form diversity of the HIV protease inhibitor ritonavir by high-throughput crystallizationStructure and mechanism of the complex between cytochrome P4503A4 and ritonavirThe crystal structure of protease Sapp1p from Candida parapsilosis in complex with the HIV protease inhibitor ritonavirRitonavir: an extraordinary example of conformational polymorphismSaquinavir and ritonavir pharmacokinetics following combined ritonavir and saquinavir (soft gelatin capsules) administrationHIV-1 protease inhibitor ritonavir modulates susceptibility to apoptosis of uninfected T cellsRole of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings.Differential inhibition of cytochrome P450 isoforms by the protease inhibitors, ritonavir, saquinavir and indinavirHuman immunodeficiency virus type 1 protease inhibitors.The topological pressure-temperature phase diagram of ritonavir, an extraordinary case of crystalline dimorphism.Ritonavir inhibits HIF-1α-mediated VEGF expression in retinal pigment epithelial cells in vitro.PH-induced nanosegregation of ritonavir to lyotropic liquid crystal of higher solubility than crystalline polymorphs.Ritonavir inhibition of calcium-activated neutral proteases.Ritonavir (Abbott protease inhibitor) proves survival benefit in late-stage AIDS.Pharmacokinetic interactions between two human immunodeficiency virus protease inhibitors, ritonavir and saquinavir.Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, ritonavir.Ritonavir: first to prolong survivalRitonavir (Norvir)Ritonavir, Abbott protease inhibitor, approvedRitonavir: expanded access begins, warning on drug interactionsAbbott laboratories files New Drug Application for ritonavirInvestigation of 2-Fold Disorder of Inhibitors and Relative Potency by Crystallizations of HIV-1 Protease in Ritonavir and Saquinavir MixturesRitonavirDrug Interaction Study With Atazanavir Administered With and Without Ritonavir and a Cytochrome P450 Substrate RosiglitazoneClinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaMolecular Modeling Evaluation of the Binding Abilities of Ritonavir and Lopinavir to Wuhan Pneumonia Coronavirus ProteasesA Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
P921
description
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
Ritonaviiri
@fi
Ritonavir
@de
Ritonavir
@es
Ritonavir
@it
Ritonavir
@nl
Ritonavir
@ro
Ritonavir
@sh
Ritonavir
@sl
Ritonavir
@vi
Rytonawir
@pl
type
label
Ritonaviiri
@fi
Ritonavir
@de
Ritonavir
@es
Ritonavir
@it
Ritonavir
@nl
Ritonavir
@ro
Ritonavir
@sh
Ritonavir
@sl
Ritonavir
@vi
Rytonawir
@pl
altLabel
155213-67-5
@fr
A-84538
@cy
A-84538
@en
ABBOTT-84538
@cy
ABBOTT-84538
@en
ABT 538
@cy
ABT 538
@en
ABT-538
@cy
ABT-538
@en
C37H48N6O5S2
@fr
prefLabel
Ritonaviiri
@fi
Ritonavir
@de
Ritonavir
@es
Ritonavir
@it
Ritonavir
@nl
Ritonavir
@ro
Ritonavir
@sh
Ritonavir
@sl
Ritonavir
@vi
Rytonawir
@pl